Skip to the main content
Open WellbeingWhat the studies actually measured

Cholesterol and blood fats

L-Carnitineand Triglycerides

Two sources here, and they say different things: one measured lower triglycerides and one found no clear difference.

How sure anyone can be

Low certainty, level 2 of 4

Further research is likely to change this.

The most certain of the two findings here; each record carries its own.

The numbers reported

One source’s range, drawn against its own line of no difference and scaled to its own numbers.

-16.02-9.44 mg/dL-2.87

This range stays on one side of the no-difference line.

Bar the confidence interval — the range the true effect is likely to sit inNotch the number the source reportedLine where there would be no difference at all

Two sources, newest first

We do not pick between these or average them into one number.

What we read is the published abstract, not the full paper, so a blank below may still be printed in the paper itself. A fixed rule worked this out from the source’s own fields. Nobody checked this rating by hand.

  • Systematic review, 2020

    Low certainty, level 2 of 4

    The effect of l-carnitine supplementation on lipid profile and glycaemic control in adults with cardiovascular risk factors: A systematic review and meta-analysis of randomized controlled clinical trials.

    Clin Nutr. 2020;39(1):110-122. doi:10.1016/j.clnu.2019.01.020. PMID:30850271.

    Number reported
    Not in the abstract
    Which way it went
    No clear difference
    Likely range
    Not in the abstract
    Source’s own words
    not reported in the abstract
    Who was studied
    Adult with cardiovascular risk factors
    Compared with
    placebo
    Amount taken
    Not in the abstract
    For how long
    Not in the abstract
    Disagreement between studies
    Not in the abstract
    Kind of record
    Journal article
    How this rating was reachedstarts at High, 2 steps down: risk of bias and imprecision
    1. Starts at High
    2. Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
    3. Imprecision brought it down to Lowthe abstract reports no confidence interval for the estimateNot in the abstract
    4. Ends at Low2 steps down.
    Checked, nothing to step it down for
    indirectness
    Inconsistency
    No disagreement reported, and no count of studies behind it

    Imprecision stops at the first check that applies; others may apply too.

    Source saved; quote checked byte-for-byte against it by software; no signature.

    Read the abstract on PubMed

  • Systematic review, 2019 · 56 studies pooled

    Very low certainty, level 1 of 4

    Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials.

    Nutr Metab Cardiovasc Dis. 2019;29(11):1151-1167. doi:10.1016/j.numecd.2019.07.012. PMID:31561944.

    This source later carried a notice: Erratum in Nutr Metab Cardiovasc Dis. 2020 Mar 9;30(3):545. doi: 10.1016/j.numecd.2019.12.001. The number below is exactly as the source gave it.

    Number reported
    -9.44 mg/dL
    Which way it went
    Lower
    Likely range
    -16.02 to -2.87
    Source’s own words
    mg/dl triglycerides, mean difference vs control
    Who was studied
    Adult
    Compared with
    placebo or control
    Amount taken
    Recorded detail — mg/d
    For how long
    Not in the abstract
    Disagreement between studies
    I2 = 91.8%
    Kind of record
    Journal article
    How this rating was reachedstarts at High, 3 steps down: risk of bias, imprecision and inconsistency
    1. Starts at High
    2. Risk of bias brought it down to Moderatethe abstract reports no risk-of-bias or quality appraisal, so study limitations cannot be ruled outNot in the abstract
    3. Imprecision brought it down to Lowthe abstract does not state how many participants were pooledNot in the abstract
    4. Inconsistency brought it down to Very lowheterogeneity across pooled studies is high (I² = 91.8%)Reported in the abstract
    5. Ends at Very low3 steps down.
    Checked, nothing to step it down for
    indirectness

    Imprecision stops at the first check that applies; others may apply too.

    AI review could not confirm it — an AI agent re-read this finding against the saved source and at least one check failed. The batch record names the check and quotes the sentence that caused the doubt. No person read it.

    Read the abstract on PubMed

What is still missing from these readings

  • One give no number at all, only which way it went.
  • One gives no likely range, so how precise that number is is unknown.
  • Two do not say how many people took part.
  • Amount taken — One of Two readings: Not in the abstract.
  • For how long — Not in the abstract.

Something nobody wrote down is never a zero and never a guess.

Still to read for L-Carnitine

Eight of the 20 things on our list for L-Carnitine have no reading here yet:

  • Creatine Kinase (CK)
  • Fatigue
  • Muscle soreness
  • Muscular Endurance
  • Six-Minute Walk Test Distance
  • Sperm concentration
  • TMAO (trimethylamine-N-oxide)
  • Total carnitine (plasma)

Still to read means nobody here has got to it, not that it was tried and did nothing or that no research exists. A pairing on no list is not a gap: we never set out to read it.

Read next

This is a library, not advice. No recommendation, no dose, no diagnosis, no ranking. We never ask about your symptoms, and nothing here is tailored to you.